Dueren, Germany

Sven Kuehnert

USPTO Granted Patents = 16 


Average Co-Inventor Count = 6.6

ph-index = 5

Forward Citations = 53(Granted Patents)


Company Filing History:


Years Active: 2007-2020

Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents

Title: Sven Kuehnert: Pioneering Innovations in Medicine

Introduction:

Sven Kuehnert, a visionary inventor hailing from Dueren, Germany, is a trailblazer in the field of pharmaceutical innovations. With a keen passion for pushing the boundaries of technology and a relentless pursuit of excellence, Kuehnert continues to inspire the next generation of inventors worldwide.

Latest Patents:

Kuehnert's latest patents showcase his expertise in the pharmaceutical domain:

1. "3-((hetero-)aryl)-alkyl-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives" - This invention pertains to novel derivatives with applications in medicine, particularly in the treatment of pain.

2. "3-((hetero-)aryl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives" - Another groundbreaking invention by Kuehnert that offers significant potential in the medical field.

Career Highlights:

During his illustrious career, Kuehnert has made significant contributions while working at renowned companies like Grünenthal GmbH. His dedication to innovation and his knack for problem-solving have earned him accolades within the industry.

Collaborations:

Kuehnert has had the privilege of collaborating with esteemed professionals in the field, including Wolfgang Schroeder and Klaus Schiene. This collaboration has led to the development of cutting-edge solutions that have left a lasting impact on the pharmaceutical landscape.

Conclusion:

In conclusion, Sven Kuehnert's innovative spirit and unwavering commitment to excellence underscore his position as a driving force in the field of pharmaceutical inventions. His groundbreaking work continues to shape the future of medicine, leaving an indelible mark on the industry and inspiring generations to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…